New!Radiotherapy Cuts BRCA-Associated Contralateral Breast Cancer Risk
Prophylactic contralateral (CLT) breast radiotherapy was associated with significantly fewer and delayed cases of breast cancer in women having standard therapy for their ipsilateral BRCA mutation-associated breast cancers in a study from Israel reported in a poster session at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
New! Targeted Therapy in Breast Cancer Continues to Evolve
Most patients with ER-positive and HER2-positive breast cancer will do well on endocrine therapy for some time, but eventually almost all patients acquire resistance and require chemotherapy to maintain disease control.